Skip to main content
OpenTrials

Clinical trial condition

Colorectal Neoplasms

Explore clinical trials studying Colorectal Neoplasms. Study availability and eligibility vary by location and protocol.

4,238 public trials 880 recruiting studies
Refine in advanced search Browse all conditions

Colorectal Neoplasms trial results

Completed

Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer

NCT00063141

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • ImClone Investigational Site Tucson, Arizona, United States
  • ImClone Investigational Site Pine Bluff, Arkansas, United States
  • ImClone Investigational Site Bakersfield, California, United States
  • ImClone Investigational Site Berkeley, California, United States
View all 188 locations
View Trial Details
Completed

A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer

NCT00055419

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
Locations
  • ImClone Investigational Site Bakersfield, California, United States
  • ImClone Investigational Site Los Angeles, California, United States
  • ImClone Investigational Site Denver, Colorado, United States
  • ImClone Investigational Site Torrington, Connecticut, United States
View all 29 locations
View Trial Details
Completed

Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer

NCT01024504

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupoli, Greece
  • Air Forces Military Hospital of Athens Athens, Greece
  • IASO General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece
  • Laikon General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece
View Trial Details
Completed

Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.

NCT00101686

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
Locations
  • Pfizer Investigational Site Birmgingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmngham, Alabama, United States
  • Pfizer Investigational Site Mobile, Alabama, United States
View all 175 locations
View Trial Details

Related conditions